China - Blog

The article provides evidence checklist for trade mark disputes in China

This article is a primer on the various categories of pharmaceutical patents in China.

On 17 October 2020, China approved the fourth amendment to the China Patent Law (CPL), which will take effect on 1 June 2021.

On October 17 2020, Xinhua News Agency revealed the progress of the revision of eight laws, which includes the fourth revision of the PRC Patent Law

Equivalence infringement, or the doctrine of equivalence, was officially introduced into Chinese patent law legislation in 2009, through the...

COVID-19 is rapidly changing the way we live as well as the way we do business.

On July 3, 2020, China released the second draft amendments to the Patent Law.

Real names on fake products. China has often faced this problem in the past thirty years, also in the spirits industry.

COVID-19 has swept across the globe causing massive disruption to businesses everywhere.

For years Western companies have relied on Chinese factories to manufacture their products at low cost and export them back to other markets to be sol

 In consideration of the disruptions caused in many countries by the COVID-19 outbreak, the Beijing IP Court has opened the possibility for foreign

On 1 February 2020, the CNIPA brought its revisions on examining computer-related inventions (“New AIRelated Revisions”) into eff ect.

China introduced requirements for foreign-filing licences for inventions in 2010 (when the third revision of the Patent Law came into force).

Reading article 14 TML, we understand that a WKTM is a trademark that is extensively used and advertised, and enjoys high reputation in its field…